Seagen Inc (SGEN):企業の財務・戦略的SWOT分析

◆英語タイトル:Seagen Inc (SGEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4301FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Seagen Inc (SGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Seagen Inc (Seagen), formerly Seattle Genetics Inc, is a biotechnology company that discovers, develops and markets monoclonal antibody-based therapies for the treatment of cancer. It markets antibody-drug conjugates (ADCs) including Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma, T-cell lymphomas, and CD30-expressing lymphomas; and Padcevtm (enfortumab vedotin-ejfv) to treat metastatic urothelial cancers. The company’s pipeline consists of novel therapies that for addressing the unmet medical needs of blood-related cancers and solid tumors. Seagen products and pipeline are based on ADC technology that targets monoclonal antibodies and delivers agents for killing cancer cells. The company sells its products through specialty distributors. Seagen is headquartered in Bothell, Washington, the US.

Seagen Inc Key Recent Developments

Feb 24,2021: Seagen to Present at the Cowen 41st Annual Healthcare Conference
Feb 11,2021: Seagen Reports Fourth Quarter and Full Year 2020 Financial Results
Nov 09,2020: Seagen highlights immuno-oncology data from broad portfolio during SITC Virtual Annual Meeting 2020
Oct 29,2020: Seagen reports third quarter 2020 financial results
Oct 08,2020: Seattle Genetics announces corporate name change to Seagen

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Seagen Inc – Key Facts
Seagen Inc – Key Employees
Seagen Inc – Key Employee Biographies
Seagen Inc – Major Products and Services
Seagen Inc – History
Seagen Inc – Company Statement
Seagen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Seagen Inc – Business Description
Business Segment: Collaboration and License Agreement Revenue
Performance
Business Segment: Net Product Sales
Performance
Business Segment: Royalty Revenues
Performance
R&D Overview
Seagen Inc – Corporate Strategy
Seagen Inc – SWOT Analysis
SWOT Analysis – Overview
Seagen Inc – Strengths
Seagen Inc – Weaknesses
Seagen Inc – Opportunities
Seagen Inc – Threats
Seagen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Seagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Seagen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Seagen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 24, 2021: Seagen to Present at the Cowen 41st Annual Healthcare Conference
Feb 11, 2021: Seagen Reports Fourth Quarter and Full Year 2020 Financial Results
Nov 09, 2020: Seagen highlights immuno-oncology data from broad portfolio during SITC Virtual Annual Meeting 2020
Oct 29, 2020: Seagen reports third quarter 2020 financial results
Oct 08, 2020: Seattle Genetics announces corporate name change to Seagen
Aug 27, 2020: Seattle Genetics highlights data from broad oncology portfolio during ESMO Virtual Congress 2020
Aug 18, 2020: Seattle Genetics appoints Ted W. Love, M.D., to Board of Directors
Jul 30, 2020: Seattle Genetics reports second quarter 2020 financial results
May 13, 2020: Seattle Genetics highlights data from expanding oncology portfolio during virtual scientific program of the 2020 ASCO annual meeting
Apr 30, 2020: Seattle Genetics reports first quarter 2020 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Seagen Inc, Key Facts
Seagen Inc, Key Employees
Seagen Inc, Key Employee Biographies
Seagen Inc, Major Products and Services
Seagen Inc, History
Seagen Inc, Subsidiaries
Seagen Inc, Key Competitors
Seagen Inc, Ratios based on current share price
Seagen Inc, Annual Ratios
Seagen Inc, Annual Ratios (Cont...1)
Seagen Inc, Interim Ratios
Seagen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Seagen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Seagen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Seagen Inc (SGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KAMCO Investment Company K.S.C.P. (KAMCO):企業の財務・戦略的SWOT分析
    KAMCO Investment Company K.S.C.P. (KAMCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Transportadora De Gas Del Sur S.A.
    Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report Summary Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • C-Rad AB (CRAD B):医療機器:M&Aディール及び事業提携情報
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務分析
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • International Finance Corp:企業の戦略的SWOT分析
    International Finance Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Henry Schein Inc (HSIC):医療機器:M&Aディール及び事業提携情報
    Summary Henry Schein Inc (Henry Schein) is a distributor of medical, dental and veterinary products including vaccines, medicines and equipment. Its product portfolio consists of dental, medical and animal health products, software and technology and other value-added services, besides financial ser …
  • ICU Medical Inc (ICUI)-医療機器分野:企業M&A・提携分析
    Summary ICU Medical Inc (ICU Medical) is a medical device company which develops, manufactures, distributes and sells devices used for infusion therapy, cancer diagnosis and treatment and critical care applications. The company’s major products include needle free vascular access devices, closed sys …
  • Cingulate Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Cingulate Therapeutics LLC (Cingulate) is a clinical stage biopharmaceutical company that develops new drug products for the treatment of attention deficit and hyperactivity disorder. The company’s pipeline products comprise CTX-1301 and CTX-1302 utilize precision timed release (PTR) drug de …
  • Technicolor SA:企業の戦略・SWOT・財務情報
    Technicolor SA - Strategy, SWOT and Corporate Finance Report Summary Technicolor SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • HCA Healthcare Inc (HCA):製薬・医療:M&Aディール及び事業提携情報
    Summary HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and an …
  • Epizyme Inc (EPZM):製薬・医療:M&Aディール及び事業提携情報
    Summary Epizyme, Inc. (Epizyme) is a biopharmaceutical company that develops novel epigenetic therapies for the treatment of cancer and other disorders. The company discovers and develops small molecule inhibitors of a class of enzymes, namely, histone methyl transferases (HMTs) and other chromatin …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Rutherford Electric Membership Corp:企業の戦略的SWOT分析
    Rutherford Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Patel Engineering Ltd
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Calavo Growers, Inc. (CVGW):企業の財務・戦略的SWOT分析
    Calavo Growers, Inc. (CVGW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Oneness Biotech Co Ltd (4743):企業の財務・戦略的SWOT分析
    Summary Oneness Biotech Co Ltd (Oneness Biotech) is a bio pharmaceutical company that conducts research and development of drugs. The company provides products such as anti acne products. Its technologies comprise GAP cultivation platform, medicinal material identification, and separation and purifi …
  • Navid Zar Chimi Ind Co:企業の戦略的SWOT分析
    Navid Zar Chimi Ind Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Jura Energy Corp (JEC):企業の財務・戦略的SWOT分析
    Jura Energy Corp (JEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Deoleo SA:企業の戦略・SWOT・財務分析
    Deoleo SA - Strategy, SWOT and Corporate Finance Report Summary Deoleo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Hunter Engineering Co:企業の戦略的SWOT分析
    Hunter Engineering Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆